Literature DB >> 32521170

Reply to Ward et al.: Clonally Related Viable Nontuberculous Mycobacteria in Gastric Juice and Sputum in People with Cystic Fibrosis.

Jennifer R Honda1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32521170      PMCID: PMC7528803          DOI: 10.1164/rccm.202005-1802LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
From the Authors: We appreciate the congratulations offered by Ward and colleagues regarding our recent publication on the possible link between nontuberculous mycobacterial (NTM) pulmonary disease (PD) and gastroesophageal reflux disease (GERD) (1). As a basic-science laboratory dedicated to learning more about the biology, microbiology, and immunology of environmentally acquired NTM infections, the intersection of our work with gastroenterology is intriguing and timely. In the past, this group has certainly provided important data regarding the presence of Pseudomonas aeruginosa and Mycobacterium abscessus in gastric fluids and sputum of patients with cystic fibrosis (2, 3). Though both our groups commonly highlight a role for rapid-growing M. abscessus in the context of GERD, we believe that the slow-growing M. avium complex species will also emerge as an important group of NTM to investigate in future studies. Already, our colleagues have demonstrated the high prevalence of GERD in patients with M. avium complex PD (4, 5). We are in full concurrence with Ward and colleagues regarding the growing importance of the “aerodigestive” interaction for both the respiratory and gastrointestinal fields and believe this is a necessary and certainly opportune research area. We are delighted and thankful for our common interests and encourage other enthusiasts of NTM PD and cystic fibrosis to join us in studying the pathogenesis of NTM PD-GERD.
  4 in total

1.  Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease.

Authors:  Won-Jung Koh; Jun Haeng Lee; Yong Soo Kwon; Kyung Soo Lee; Gee Young Suh; Man Pyo Chung; Hojoong Kim; O Jung Kwon
Journal:  Chest       Date:  2007-03-30       Impact factor: 9.410

2.  Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease.

Authors:  Rachel M Thomson; John G Armstrong; David F Looke
Journal:  Chest       Date:  2007-04       Impact factor: 9.410

3.  Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients.

Authors:  H Al-Momani; A Perry; C J Stewart; R Jones; A Krishnan; A G Robertson; S Bourke; S Doe; S P Cummings; A Anderson; T Forrest; S M Griffin; M Brodlie; J Pearson; C Ward
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

4.  Nontuberculous mycobacteria in gastrostomy fed patients with cystic fibrosis.

Authors:  H Al-Momani; A Perry; R Jones; S Bourke; S Doe; J Perry; A Anderson; T Forrest; I Forrest; M Griffin; M Brodlie; J Pearson; C Ward
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.